Share

COVID-19 Impact on Contract Development and Manufacturing Organization Market

The contract manufacturing organization segment is projected to unlock lucrative opportunities for the growth of the market

Share
Contract research organisation, COVID-19 pandemic, Contract development and manufacturing organisations, Contract development, Manufacturing organisations

The unexpected rise of COVID-19 disease has created a positive impact on the financial growth of numerous countries worldwide. A latest report by Research Dive divulges that the Contract Development and Manufacturing Organisation Market is projected to gather $315.7 billion by 2026, rising at a CAGR of 12.4% from 2019 to 2026. The report states that this market is expected to experience significant growth after the end of this pandemic. It offers a comprehensive analysis of the COVID-19 impact on the drivers & limitations, key segments, opportunities, and major players of the global industry.

Factors Driving the Market Growth amidst COVID-19 Crisis

Several organizations will be in an attempt to speed up their productivity to fulfill the growing demand, after the end of the covid-19 pandemic.  Such bigger companies are therefore, expected to appoint contract development and manufacturing organisations to overcome the losses suffered in the course of the crisis. Furthermore, numerous government bodies are coming up with innovative plans to fuel the growth of contract development and manufacturing organisations; so that these organizations can support the other larger organizations to upsurge their productivity.

Contract Manufacturing Organization Segment Anticipated to Unlock Lucrative Growth Opportunities

Based on service, the report categorizes the market into contract manufacturing organisation and contract research organisation. Among these, the contract manufacturing organization segment is expected to garner $224.1 billion by 2026, rising at a CAGR of 12.1% throughout the projected period. Contract development and manufacturing organizations are specifically beneficial in medical industries for manufacturing of medicines, trials of drugs, and commercial medications.

Regional Outlook of the Market

Based on region, the report assesses the market across Europe, North America, Asia-Pacific, and LAMEA. Among these, the Asia-Pacific market is expected to progress with a CAGR of 13.2% throughout the projected period. This is chiefly due to the presence of many major companies and accessibility of reasonably priced labor force in this region.

Newsletter

Most Popular

Digital Edition

july 2020
From the magazine

Subscribe Now